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Drug use by music festival attendees: A novel triangulation approach using self-reported 
data and test results of oral fluid and pooled urine samples 
 
ABSTRACT 
Background: Self-reported data are commonly used when investigating illicit substance use. 
However, self-reports have well-known limitations such as limited recall and socially 
desirable responding. Mislabeling or adulteration of drugs on the illicit market may also cause 
incorrect reporting.  
Objectives: We aimed to examine what could be gained in terms of illicit drug use findings 
among music festival attendees when including biological sample test results in the 
assessment. 
Methods: We included 651 attendees at three music festivals in Norway from June to August 
2016. Self-reported drug use was recorded using questionnaires, and samples of oral fluid 
were analyzed to detect use of illicit drugs. In addition, we analyzed samples of pooled urine 
from portable toilets at each festival.  
Results: All methods identified cannabis, MDMA, and cocaine as the most commonly used 
drugs. Overall, 6.6% of respondents reported use of illicit substances during the previous 48 
hours. Oral fluid testing identified a larger number of drug users as 12.6% tested positive for 
illicit drugs. In oral fluid testing, we identified ketamine and three new psychoactive 
substances (NPS) that had not been reported on the questionnaire. In pooled urine testing, we 
identified amphetamine and three additional NPS that were neither reported used nor found in 
oral fluid samples.   
Conclusions/Importance: Drug testing of biological samples proved to be an important 
supplement to self-reports as a larger number of illicit substances could be detected. 
 
 
Keywords: recreational drug use; illicit drugs; music festivals; self-reported drug use; oral 
fluid; pooled urine; drug testing 
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Introduction 
Illicit substance use is most commonly studied using self-reported data collected via 
questionnaires and/or interviews (Johnson & VanGeest, 2017; Sloboda, 2002). In addition to 
detailed information on drug use and consumption history, individual data on a range of 
potentially important variables can be collected for every respondent. However, self-reports 
have well-known limitations, such as under- or overreporting of actual drug use. Incorrect 
reporting may result from factors such as limited recall and socially desirable responding 
(Johnson & Richter, 2004; Johnson & Fendrich, 2005). Selection bias may be a problem, 
either because participants are non-randomly recruited or because some subgroups may have a 
lower probability of participation (Harrison & Hughes, 1997; Johnson, 2014). One particular 
problem for studies on the use of illegal drugs is that users may not know exactly what they 
have consumed (EMCDDA, 2016b; Tanner-Smith, 2006; Togni, Lanaro, Resende, & Costa, 
2015; Vogels et al., 2009). The problem may apply in particular to inexperienced users, but 
even experienced users may not always know the true content of the substances used. This 
problem may have increased in recent years as a large number of so-called New Psychoactive 
Substances (NPS) have appeared on the drug market. NPS are defined as new narcotic or 
psychotropic drugs that were not included in the United Nations’ Single Convention on 
Narcotic Drugs (UNODC, 1961) or the Psychotropic Substances Convention (UNODC, 
1971). These mainly include synthetic stimulants, depressants, hallucinogens, and 
cannabinoids (EMCDDA, 2017; Nelson, Bryant, & Aks, 2014), but some plant-based drugs 
may also be classified as NPS (Schifano, Orsolini, Duccio Papanti, & Corkery, 2015). In 
cases where sales information or labels exist, these may be inaccurate or misleading due to 
intended mislabeling or adulteration of common drugs with NPS (Oliver et al., 2019; Palamar 
et al. 2017; Scherbaum, Schifano, & Bonnet, 2017; UNODC, 2016) or the chemical name 
may be difficult to remember. Hence, even when reporting to the best of their knowledge, 
users may still do so incorrectly.  
An alternative to self-reports is drug testing of biological samples such as urine, oral fluid 
(saliva), sweat, hair, or blood (Fendrich, Johnson, & Becker, 2017; Fendrich, Johnson, Wislar, 
Hubbell, & Spiehler, 2004; Gjerde, Øiestad, & Christophersen, 2011; Salomone, Palamar, 
Gerace, Di Corcia, & Vincenti, 2017), which may be used to detect recent use of a wide range 
of substances. However, the refusal rate may be high if the sample collection is regarded as 
intrusive (Gjerde, Øiestad, & Christophersen, 2011). Fendrich and co-workers found in a 
population survey that about 10% refused to give a sample of oral fluid, whereas about 24% 
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refused to provide urine sample (Fendrich, Johnson, Wislar, & Hubbell, 2004). Some 
participants may fear that drug findings may be traced to the sample provider. Low 
participation rates may introduce a significant selection bias. Further, analysis of NPS 
presents a challenge compared with that of classical illicit drugs due to the large number of 
new substances and rapid changes in availability, as well as a complex pattern of metabolites 
in urine samples.  
Wastewater-based epidemiology (WBE) has been recognized as a complementary tool for 
objectively monitoring the use of illicit drugs at population level (Bade et al., 2017; Brewer, 
Banta-Green, Ort, Robel, & Field, 2016; Burgard, Banta-Green, & Field, 2014; Thomas et al., 
2012; Zuccato, Chiabrando, Castiglioni, Bagnati, & Fanelli, 2008). The methodology has 
recently also been explored for NPS (Bade et al., 2017; Gonzalez-Marino, Gracia-Lor, Rousis, 
et al., 2016); in the latter case, the above challenges also exist for WBE in relation to the low 
incidence of NPS use and therefore low concentrations in wastewater.  
As an alternative to wastewater, analysis of pooled urine samples can be used to evaluate the 
consumption of both classical and new psychoactive drugs (Archer, Hudson, Wood, & 
Dargan, 2013; Mardal et al., 2017). Drug concentrations are obviously higher in pooled urine 
than in wastewater due to the much lower dilution factor, thereby increasing the possibility of 
detecting rarely used drugs, which is an important advantage. Few samples are needed, and a 
large number of different substances can be analyzed using the same sample, which represents 
a large number of individuals. As with wastewater testing, informed consent from individuals 
is not needed, and the sampling process is neither intrusive nor invasive. A disadvantage is 
that information about the participants is difficult to collect, including the number of people 
contributing to the pooled urine sample. Therefore, pooled urine testing does not contribute to 
estimating prevalence of illicit drug use. Nevertheless, pooled urine testing is a useful tool for 
determining the types of drugs consumed. 
Advanced analytical methodologies are required to examine drugs in wastewater, pooled 
urine, oral fluid, or other biological samples, particularly for NPS (Hernandez et al., 2018). 
The most common approach is the monitoring of only specified substances. This allows 
quantification of very low drug concentrations in the samples, using techniques like liquid 
chromatography (LC) coupled to tandem mass spectrometry (MS/MS). Although this 
approach is highly useful and robust, it cannot be used to detect drugs that are not among the 
targeted compounds. Alternatively, the use of LC coupled to high-resolution mass 
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spectrometry (HRMS), linked to large mass spectral libraries, enables qualitative screening 
(i.e., detection and identification) of a large number of drugs, when quantification is not a 
primary objective. This is of particular relevance when many drugs are investigated, and/or 
when reference standards are not all available in the laboratory, which is a common situation 
when dealing with NPS.  
Studies of nightlife settings and events such as music festivals have reported high rates of 
illicit substance use (Bijlsma, Serrano, Ferrer, Tormos, & Hernandez, 2014; Gripenberg-
Abdon et al., 2012; Hesse & Tutenges, 2012; Hoegberg et al., 2018; Jenkinson, Bowring, 
Dietze, Hellard, & Lim, 2014; Johnson, Voas, Miller, & Holder, 2009; Lim, Hellard, 
Hocking, & Aitken, 2008; Miller, Byrnes, Branner, Voas, & Johnson, 2013; Miller et al., 
2009; Miller et al., 2015; Mohr, Friscia, Yeakel, & Logan, 2018; Riley, James, Gregory, 
Dingle, & Cadger, 2001). Particularly high rates have been found at electronic dance music 
(EDM) events (Hesse & Tutenges, 2012; Johnson et al., 2009; Mohr et al., 2018; Riley et al., 
2001). In addition to the use of classical drugs such as cannabis, amphetamines, cocaine, and 
MDMA (ecstasy), the use of NPS has been detected, although at lower levels than for 
classical drugs (Hoegberg et al., 2018; Riley et al., 2001; Palamar, Acosta, Sherman, Ompad, 
& Cleland, 2016; Palamar et al., 2017).  
To the best of our knowledge, no previous studies have combined self-reported data and test 
results for drugs in oral fluid and pooled urine samples in settings such as music festivals. In 
this study, we aimed to examine what could be gained in terms of illicit drug use findings 
among music festival attendees when including biological sample test results in the 
assessment. 
 
Materials and methods 
Setting 
Norway has a population of 5.2 million and the largest city has approximately 600,000 
inhabitants. We selected three music festivals in Norway during the summer of 2016 for this 
study: a pop/rock music festival and an EDM festival, which both took place in a large city 
(>200,000 inhabitants), and a pop/rock music festival in a small town in a rural area. All three 
festivals had several thousand (8,500–20,000) visitors on each day of the festival.  
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Recruitment of participants 
At each festival site, a geographical recruitment area was defined. These were located in high-
traffic areas, such as close to the entrances or exits or near toilet facilities. Data collection 
began between 7:00 and 9:00 p.m. and continued for about 3 to 4 hours, until about 200 
participants had been recruited. All festivals had a large number of patrons passing through 
the selected area(s); it was therefore not possible to invite all patrons to participate or to use 
systematic random sampling. Consequently, this was a convenience sample. Participants were 
informed of the study and consented to taking part in the study. Data were collected using a 
questionnaire, and participants provided an oral fluid sample for drug testing. Participants 
received a voucher for food or soft drinks in lieu of reimbursement. Further details on 
participant recruitment and data collection have been previously published (Gjersing, 
Bretteville-Jensen, Furuhaugen, & Gjerde, 2019).  
Participant recruitment and collection of data and oral fluid samples were approved by the 
Regional Committee for Medical and Health Research Ethics (approval no. 2016/337). 
Self-report data 
A questionnaire for self-completion was used to record data on age, sex, education (less than 
12 years; 12–13 years; bachelor’s degree or higher), occupation (full-time job; part-time job; 
student; unemployed; sick leave), and self-reported use of cannabis, amphetamines, 
MDMA/ecstasy, cocaine, NPS, and MOP (which was a fictitious “dummy substance”, to 
study the extent of overreporting) during the previous 48 hours, previous 12 months, and 
lifetime (yes/no for each drug class). Participants were asked to report which NPS they had 
used or tried during their lifetime, not during previous 48 hours or 12 months. We did not ask 
for use of specified NPS. If someone asked if a substance was included in the NPS category, 
and the research assistants were unsure, we asked them to tick “yes” and specify the type of 
substances used. The substances reported were assessed at a later stage. 
Oral fluid samples 
Oral fluid samples were collected using the Intercept® Oral Fluid Collection Device (OraSure 
Technologies Inc., Bethlehem, PA, USA). Samples of oral fluid were analyzed to detect 
classical recreational drugs and a selection of NPS using ultra high-performance LC-MS/MS. 
The sample preparation and analytical methods have been described previously (Gjerde et al., 
2016). Samples were analyzed by testing for either the active drug or inactive metabolites; this 
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was done for classical illicit drugs (amphetamines, MDMA, cocaine, cannabis, LSD, and 
heroin) as well as for 22 NPS, which were selected based on the opinion of experts and the 
types of NPS that participants reported using (see Supplementary Table S1). Sample extracts 
were reanalyzed to confirm tentative NPS findings using LC-HRMS with a quadrupole time-
of-flight (q-TOF) mass spectrometer. Analytical data were matched with an in-house mass 
spectral library of approximately 1700 compounds. 
Pooled urine samples 
After each study day, the portable toilets on the festival grounds were emptied into a sewage 
disposal truck. Pooled urine samples were collected from the truck between 6:00 and 8:00 
a.m. The samples were analyzed for the presence of a larger number of NPS than for the oral 
fluid samples due to differences in analytical methodologies; see Supplementary Table S1 for 
details. Qualitative analyses were performed for more than 190 NPS with HRMS using both 
quadrupole-time-of-flight and Orbitrap® (Thermo Fischer Scientific, Waltham, MA, USA) 
mass spectrometers, as described elsewhere (Bade et al., 2015; Gonzalez-Marino, Gracia-Lor, 
Bagnati, et al., 2016). We used mass spectral libraries or specific publications for 
identification of substances. 
Quantitative analyses were performed with LC-MS/MS (Bade et al., 2017; Bijlsma, Beltran, 
Boix, Sancho, & Hernandez, 2014; Gonzalez-Marino, Gracia-Lor, Rousis, et al., 2016; 
Zuccato et al., 2016) for the same classical illicit drugs as listed above in oral fluid testing, 
except for LSD. Some selected NPS (mostly synthetic cathinones) were also quantified. The 
referenced quantitative methods were adapted (i.e., sample preparation and pre-concentration 
steps) and validated for the analysis of pooled urine, as these original methods were developed 
for the determination of illicit drugs and NPS in wastewater.  
For cannabis, we only tested its main metabolite, 11-nor-9-carboxy-Δ9-tetrahydrocannabinol 
(THC-COOH) in pooled urine because the active substance tetrahydrocannabinol (THC) is 
mainly metabolized to THC-COOH and excreted via urine. This metabolite is generally used 
as a stable biomarker for cannabis in wastewater analysis (Bijlsma, Serrano, et al., 2014; 
Thomas et al., 2012).  
Statistical analysis 
We used Pearson’s chi-squared test for categorical data to compare age distributions, 
education, and drug use among attendees at the three festivals. Wilson’s binomial 95% 
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confidence intervals for proportions were calculated incorporating continuity correction 
(Newcombe, 1998).  
 
Results 
Questionnaire responses 
Of the 651 study participants, 49% (n=320) were females. The proportion of participants 
younger than age 24 years was significantly higher at the EDM festival (74.1%) than the two 
pop/rock festivals (15.5% and 18.6%; χ2=201.3, p<0.001), and a larger proportion had not 
completed bachelor’s degree or higher education (66.8% among EDM festival participants 
versus 20.4% and 19.5% among participants at the pop/rock festivals; χ2=136.2, p<0.001). 
Most attendees at the pop/rock festivals had full-time jobs, and four out of five held a 
bachelor’s degree or higher. Characteristics of the three music festivals and the study cohorts 
are presented in Table 1. 
 
[Insert Tables 1 and 2 near here] 
In total, 6.6% of respondents reported use of illicit drugs during the previous 48 hours. 
Cannabis was the most commonly reported drug (5.1%), followed by MDMA (1.7%) and 
cocaine (1.1%). Cannabis was also most commonly reported drug used in the previous 12 
months (21.8%), followed by MDMA (5.7%) and cocaine (5.4%). Details for each of the three 
festivals are presented in Tables 1 and 2. A larger proportion of the participants at the EDM 
festival reported use of MDMA during the previous 48 hours (3.9%) than attendees at the 
other festivals (0.7%; χ2=8.8, p=0.003).  
Only 10 participants (1.5%) reported lifetime use of NPS, five (0.8%) during the previous 12 
months and only one within the previous 48 hours. Respondents were only asked to specify 
the types of NPS used during their lifetime and not those used in the previous 48 hours; three 
participants reported having tried synthetic cannabinoids or “spice”, two reported having used 
2C-B (a psychedelic drug), one had used Salvia divinorum, and four did not specify which 
substance they had used.  
Oral fluid test results 
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Illicit drugs were found in 12.6% of oral fluid samples, which is a significantly larger 
proportion than self-reported use during the previous 48 hours (χ2=13.5, p<0.001). The most 
commonly detected drugs were THC, cocaine, and MDMA, the proportions and frequencies 
of which varied among the three festivals (Table 2).  
Similar to the questionnaire responses, a larger proportion of participants at the EDM festival 
tested positive for MDMA (χ2=11.1, p=0.001) and cocaine (χ2=9.5, p=0.002) than attendees at 
the two pop/rock festivals. At the same time, a smaller proportion of participants tested 
positive for THC at the pop/rock festival in the small town than attendees at the two festivals 
in large cities (χ2=10.3, p=0.001). In analysis of oral fluid samples, we detected the use of 
ketamine by two persons at the EDM festival. Three NPS were detected: alpha-PVP and 2C-B 
had been used by a few participants at the large city pop/rock festival, and dimethyltryptamine 
by two participants at the small town pop/rock festival.  
Pooled urine test results 
In line with self-reports and results of oral fluid sample testing, analysis of pooled urine also 
revealed the highest proportion of MDMA use at the EDM festival. The highest 
concentrations of cocaine and its metabolite were found in the pooled urine sample from the 
pop/rock festival in the large city, with relatively high levels of MDMA detected as well. The 
sample from the small-town pop/rock festival showed the highest concentration of THC-
COOH. Ketamine was detected only in the sample from the large city pop/rock festival. 
Overall, three NPS were detected: methcathinone, 4-chloro-alpha-PPP, and 2-phenethylamine; 
all three substances were found in the sample from the large city pop/rock festival, 2-
phenethylamine also in samples from the two other festivals.  
In some cases, a drug or its metabolite was found in pooled urine but it was not found in oral 
fluid samples nor its use reported on the questionnaires (amphetamines at the two pop/rock 
festivals and cocaine at the small town pop/rock festival; Table 2). Conversely, at the EDM 
festival, the use of cannabis was confirmed in self-reports and oral fluid testing but not in the 
pooled urine test results. A comparison of the three festivals based on self-reports and oral 
fluid testing was therefore slightly different than a comparison of the festivals using the 
pooled urine test results.  
Finally, only 29 of the 82 persons (35.4%) who tested positive for illicit drugs in oral fluid, 
including NPS, reported having used the detected substance or NPS during the previous 48 
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hours. Among those who tested positive for cannabis, 51.3% reported such use during the 
previous 48 hours, whereas among those testing positive for cocaine or MDMA, only 25.5% 
reported such use (χ2=6.1, p=0.014).  
 
Discussion 
To the best of our knowledge, this is the first study of illicit drug use at music festivals that 
combines self-reports with drug testing of both oral fluid and pooled urine samples. Although 
all methods identified the three same most commonly used drugs, the biological sample test 
results identified a larger number of illicit substances than the self-reports. Drug testing of 
biological samples therefore appears to be an important supplement to self-reports when 
investigating illicit substance use. 
The biological sample test results and questionnaire responses indicated that the type of 
substances used differed among festivals. MDMA was more common among EDM festival 
attendees whereas cocaine was more common among participants at the pop/rock festival in 
the large city. At the small-town pop/rock festival, cannabis was the most commonly reported 
substance; few participants had used other drugs, as confirmed by analytical testing of oral 
fluid or pooled urine, and no one reported use of any other substance during the previous 48 
hours.  
Each of the three methods used — questionnaires, oral fluid sample testing, and pooled urine 
sample testing — have strengths and weaknesses. The use of a questionnaire enables the 
collection of sociodemographic data and information of self-reported drug use over a longer 
time period than can be detected with analysis of oral fluid or urine. We also used the 
questionnaire to collect data that are not presented in this article, such as the frequency and 
amount of drug use, other drug use habits, and some risk assessments.  
Oral fluid drug testing is a more objective method to determine recent drug use than self-
reporting. This methodology can be used to detect a large number of substances; we included 
29 individual substances in our study; however, the number of oral fluid samples was 
relatively low. Each festival had thousands of attendees per day, so the selected study cohorts 
of about 200 people per festival constituted a small fraction of the total attendees at each 
event. Consequently, it was not possible to accurately estimate the prevalence rate of 
substance use in each festival, and it is possible that we did not detect all NPS used. However, 
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the latter was the main strength of the pooled urine samples; using pooled urine testing, we 
were able to identify substances not detected using the questionnaire or in oral fluid analysis.  
It is difficult to estimate the prevalence rate of drug use based on pooled urine testing. It is 
also difficult to quantitatively compare the drug use levels at the different festivals because 
the number of participants contributing to the public toilet samples was unknown. In addition, 
the total drug dose per user might have been different at each festival.  
Overall, all three methods had individual weaknesses, but when used in combination, these 
were able to strengthen the findings.  
 
Discrepancies between self-reported data and results of oral fluid and urine testing 
The use of cocaine and MDMA during the previous 48 hours was clearly underreported. 
Underreporting was investigated in greater detail in a study including participants from six 
music festivals, including the three festivals in the present study (Gjerde, Gjersing, 
Furuhaugen, & Bretteville-Jensen, 2019). Underreporting has also been observed in previous 
studies (Gripenberg-Abdon et al., 2012; Harrison & Hughes, 1997; Johnson et al., 2009; 
Rendon, Livingston, Suzuki, Hill, & Walters, 2017); the magnitude may depend on age, sex, 
race, as well as type of drug (Harris, Griffin, McCaffrey, & Morral, 2008; Johnson, 2014; 
Rendon et al., 2017; Rosay, Najaka, & Herz, 2007). For example, there seems to be less 
hesitancy to report the use of cannabis than the use of amphetamine and cocaine in some 
settings (Gripenberg-Abdon et al., 2012; Johnson et al., 2009), possibly because the use of the 
latter drugs are more stigmatized. This seemed to be the case in our study as well. 
Drug findings in oral fluid and pooled urine samples are not directly comparable. Drug 
detection in oral fluid samples mostly reflects drug use during the previous 10–50 hours, 
depending on the type of drug, whereas drug findings in urine samples may reflect drug use 
during the previous several days (Verstraete, 2004). Analysis of pooled urine samples 
revealed some drugs that were neither reported as having been used nor found in oral fluid 
samples; this is because the drugs found in pooled urine reflected drug intake by all users of 
the portable toilets during the entire festival day and not only the selection of participants who 
provided oral fluid samples and completed the questionnaire. The reason for not detecting the 
same NPS in pooled urine as those detected by oral fluid testing was probably that the drug 
concentrations in pooled urine were too low, either because of few users or because of drug 
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metabolism before excreted in urine. Many NPS are extensively metabolized, therefore 
mainly metabolites of those drugs can be found in urine with very low concentrations of the 
parent drugs (Favretto et al., 2013). Further undetectable substances may therefore have been 
consumed. 
The discrepancy for cannabis at the EDM festival suggests that pooled urine testing is less 
sensitive than oral fluid testing in detection of cannabis use; this has also been previously 
reported to be a challenge in wastewater drug testing (Causanilles et al., 2017).  
Furthermore, drugs might have been intentionally or unintentionally dumped into the public 
toilets, causing elevated drug concentrations that do not reflect actual drug use. The latter 
might have occurred for cocaine, as the observed ratio between cocaine and benzoylecgonine 
concentrations (3.4 and 1.8 for the two pop/rock festivals, respectively) was much higher than 
the commonly observed concentration ratios in wastewater (0.42±0.28), which reflects the 
excretion rate of human metabolism (EMCDDA, 2016a). 
Combining the three methods 
The findings when using the three methods were somewhat different; no single method gave a 
complete picture of drug use in the studied cohorts. Combining the three types of data, each 
with distinctive pros and cons, gave the most comprehensive picture of drug use. The three 
methods had advantages and limitations, with some overlapping information regarding 
qualitative data.  
Self-reports and oral fluid samples provided specific information on the prevalence of 
individual drug use, including some NPS. The proportion who reported drug use during 
previous 48 hours was lower than the prevalence of drug findings in oral fluid samples due to 
under-reporting. However, self-reported data was needed to obtain information about drug use 
during the previous month, year and during lifetime as well as other information. 
Pooled urine analysis is not well suited to study drug prevalence, but may instead show 
generic use in the studied cohorts. The wide-scope screening methodologies used and the 
large number of festival attendees contributing to the urine samples allowed for the potential 
detection of a very large number of drugs (190 NPS plus all traditional drugs); therefore, we 
were able to detect drugs whose use had not been reported.  
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The results indicated that neither amphetamine, methamphetamine, ketamine, cathinones, 
phenethylamines nor other NPS were used by a significant proportion of the participants. 
From other sources we know that the prevalence of NPS use is low in Norway (EMCDDA, 
2018). 
 
Conclusions 
The combination of three methods used in this study provided the most complete picture of 
illicit drug use. Although all methods identified the same three most commonly used drugs, 
the biological sample test results identified a larger number of illicit substances than the self-
reports. Analysis of pooled urine samples did not add information on the prevalence of drug 
use, but identified some drugs that had been used by a small number of participants. Drugs 
used by few individuals may, however, not always be detected in pooled urine due to low 
concentrations. The drug testing of biological samples proved to be an important supplement 
to self-reporting. Future studies examining the type of substances used in a specific setting 
have much to gain by the addition of these methods. More comprehensive drug use data may 
indicate which measures are needed to reduce drug related harm and contribute to better 
policy making. 
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Table 1. Characteristics of music festivals and participants. 
 Pop/rock 
festival (large 
city) 
EDM festival 
(large city) 
Pop/rock 
festival (small 
town) 
No. of attendees (approximate, per d) 20,000 18,000 8,500 
No. of study participants 226 205 220 
Response rate (%) 60.2 53.7 77.5 
Male sex (%) 46.5 54.1 47.3 
Age, y (%)    
   16–23 15.5 74.1* 18.6 
   24–30 47.3 21.5 41.8 
   31–40 25.7 3.9* 25.9 
   41+ 10.6 0.0* 13.6 
   Not recorded 0.9 0.5 0.0 
Education (%)     
   Bachelor’s degree or higher 79.6 33.2* 80.5 
Employment status, previous 30 d (%)    
   Full-time 72.6 42.4* 69.1 
   Part-time or student 23.0 52.7 24.1 
   Unemployed 4.4 4.9 6.4 
   Not recorded 0.0 0.0 0.5 
Self-report drug use, previous 12 mo (%)    
   Amphetamines 2.7 5.9 0.5 
   Cocaine 6.6 7.3 2.3 
   MDMA 6.6 10.0§ 0.9 
   Cannabis 23.5 23.9 18.2 
   NPS 0.0 1.5 0.9 
   MOP 0.0 1.5 0.0 
*p<.001, §p<.005 when comparing participants at the EDM and the two pop/rock festivals. 
Abbreviations: EDM, electronic dance music; NPS, new psychoactive substances. MOP, a fictitious 
“dummy substance”, to study the extent of overreporting.
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Table 2. Quantitative and qualitative results of analysis of pooled urine and oral fluid, and self-reported use of illicit drugs and NPS in the 
previous 48 hours. 
 Pop/rock festival (large city)  EDM festival (large city)  Pop/rock festival (small town)  
Drug testing Self-reported 
use previous 
48 h  
% (95% CI) 
Drug testing Self-reported 
use previous 
48 h  
% (95% CI) 
Drug testing Self-reported 
use previous 
48 h  
% (95% CI) 
Pooled 
urine 
(µg/L) 
Oral fluid 
% (95% CI) 
Pooled 
urine 
(µg/L) 
Oral fluid 
% (95% CI) 
Pooled urine 
(µg/L) 
Oral fluid 
% (95% CI) 
Amphetamine 4.9 0.0 (0.0-2.1) 0.0 (0.0-2.1) 5.4 0.0 (0.0-2.3) 1.0 (0.2-3.9) 8.3 0.0 (0.0-2.1) 0.0 (0.0-2.1) 
Methamphetamine 3.8 0.0 (0.0-2.1) – 1.6 0.0 (0.0-2.3) – 1.6 0.0 (0.0-2.1) – 
Cocaine 46.2 4.0 (2.0-7.7) 1.3 (0.3-4.2) 7.9 6.8 (3.9-11.4) 2.0 (0.6-5.3) 1.7 0.0 (0.0-2.1) 0.0 (0.0-2.1) 
   Benzoylecgoninea 13.4 1.8 (0.6-4.8) – 11.0 2.0 (0.6-5.3) – 0.9 0.0 (0.0-2.1) – 
MDMA (ecstasy) 28.6 4.0 (2.0-7.7) 1.3 (0.3-4.2) 38.3 7.3 (4.3-12.0) 3.9 (1.8-7.8) 3.0 0.0 (0.0-2.1) 0.0 (0.0-2.1) 
Cannabis  – – 5.8 (3.2-9.9) – – 7.8 (4.7-12.6) – – 1.8 (0.6-4.9) 
   THC n.a. 8.8 (5.8-13.5) – n.a. 7.3 (4.3-12.0) – n.a. 1.8 (0.6-4.9) – 
   THC-COOHb 1.3 n.a. – 0.0 n.a. – 3.3 n.a. – 
Ketamine 0.1 0.0 (0.0-2.1) – 0.0 1.0 (0.2-3.9) – 0.0 0.0 (0.0-2.1) – 
NPS See below 1.3 (0.3-4.2) 0.0 (0.0-2.1) See below 0.0 (0.0-2.3) 0.5 (0.0-3.1) See below 0.9 (0.2-3.6) 0.0 (0.0-2.1) 
Methcathinone 0.3 n.a. – 0.0 n.a. – 0.0 n.a. – 
4-chloro-alpha-PPP Positivec n.a. – n.a. n.a. – n.a. n.a. – 
2-phenethylamine Positive n.a. – Positive n.a. – Positive n.a. – 
Alpha-PVP 0.0 0.4 (0.0-2.8) – n.a. 0.0 (0.0-2.3) – n.a. 0.0 (0.0-2.1) – 
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Dimethyltryptamine n.a. 0.0 (0.0-2.1) – n.a. 0.0 (0.0-2.3) – n.a. 0.9 (0.2-3.6) – 
2C-B n.a. 0.9 (0.2-3.5) – n.a. 0.0 (0.0-2.3) – n.a. 0.0 (0.0-2.1) – 
aInactive metabolite of cocaine. 
bInactive metabolite of THC.  
cTested positive, not quantified.  
n.a.: not analyzed.   
–: not queried or not applicable.
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Supplementary material  
Table S1. Cut-off concentrations for illicit substances analyzed in oral fluid or pooled urine 
samples using quantitative methods. 
Illicit substance Neat oral fluid 
(µg/L)a 
Pooled urine 
(µg/L) 
   
    Cannabis   
        Tetrahydrocannabinol 0.37 n.a. 
        Carboxy-tetrahydrocannabinol n.a. 0.060 
    Central stimulants   
        Amphetamine 15 0.10 
        Benzoylecgonine 4.3 0.060 
        Cocaine 1.1 0.060 
        MDMA (ecstasy) 2.3 0.060 
        Methamphetamine 8.9 0.060 
    Illicit opiate   
        Heroin n.a. 0.10 
        6-monoacetylmorphine 4.7 0.060 
    Hallucinogens   
        LSD 0.019 n.a. 
        Ketamine 0.34 0.060 
        Salvinorin A 3.1 n.a. 
    NPSb   
        25B-NBOMe n.a. 0.10 
        25C-NBOMe 0.048 0.10 
        25I-NBOMe 0.062 0.10 
        2C-B 0.23 n.a. 
        2C-I 0.28 n.a. 
        3,4-dimethylcathinone n.a. 0.060 
        3,4-methylenedioxy-pyrovalerone 0.50 0.060 
        4-fluoromethcathinone n.a 0.060 
        4-methylamphetamine 0.54 n.a. 
        4-methylcathinone n.a. 0.060 
        5F-APINACA 0.093 n.a. 
        5F-PB-22 0.091 n.a. 
        Alpha-PVP 0.13 0.10 
        AM-2201 0.087 n.a. 
        Buphedrone n.a. 0.060 
        Butylone n.a. 0.060 
        Diclazepam 0.19 n.a. 
        Dimethyltryptamine 0.11 n.a. 
        Ethcathinone n.a. 0.060 
        Ethylone n.a. 0.060 
        Ethylphenidate 0.15 n.a. 
        Etizolam 0.22 n.a. 
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        Flubromazepam 0.20 n.a. 
        Flubromazolam 0.22 n.a. 
 
 
Table S1 continued. 
  
Substance 
Neat oral fluid 
(µg/L)a 
Pooled urine 
(µg/L) 
        Mephedrone 0.11 0.060 
        Methcathinone n.a. 0.060 
        Methedrone n.a. 0.060 
        Methiopropamine 0.087 n.a. 
        Methylone n.a. 0.060 
        Naphyrone n.a. 0.060 
        Penthedrone n.a. 0.060 
        Pentylone n.a. 0.060 
        THJ-2201 0.087 n.a. 
        UR-144 0.075 n.a. 
aAssuming that 0.4 mL oral fluid was collected and mixed with 0.8 mL preservative buffer. 
bThe listed substances were defined as NPS in this study.   
n.a.: not analyzed. 
